Guard Therapeutics International AB
Save
188.15M
Market cap
Current P/E
0.49x
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019.

Similar securities

Based on sector and market capitalization

Report issue